Biotech Values

[turtlepower]

FOLD - Don't you think it was oversold/undervalued to begin with? The EV was approximately 40 M this morning. They have cash runway till mid 2013 so there may not be an immediate cash raise. That said this stock has been volatile and has doubled since November. I wouldn't be surprised if it pulls back tomorrow or next week before settling down in the 6's until the PIII data is announced. I think one noteworthy aspect of the presentation was about the ongoing trial and how most participants who had completed were enrolling in the open label trial. This piece of information in addition to the physician initiated request trial that opened in december probably leads investors to believe 011 will be positive.